Pro-Am for Alzheimer's
Baycrest

About Baycrest Foundation

The Baycrest Foundation’s mission is to enrich the quality of life of our community by supporting programs and services that promote excellence in care, research, education and innovation in the field of aging. The Foundation helps provide crucial funding to Baycrest Health Sciences to support areas such as: ongoing medical programs and services for seniors living in our community; innovative research into cognition, Alzheimer’s disease, dementia, stroke and aging brain health; and local, national, and international education that supports healthy aging and healthcare solutions for a growing senior population.


About Baycrest Health Sciences

Headquartered on a 22-acre campus in Ontario and fully affiliated with the University of Toronto, Baycrest is the global leader in developing and providing innovations in aging and brain health. It is also home to the Rotman Research Institute (RRI), one of the world’s top cognitive brain health research institutes.

Baycrest is unique in the world, combining a comprehensive system of care for aging patients, one of the world’s top 5 research institutes in cognitive neuroscience, dedicated centres focused on mitigating the impact of age-related illness and impairment, and unmatched global knowledge exchange and commercialization capacity.

Baycrest serves about 1,200 community members daily; operates a 472-bed nursing home and a 262-bed hospital complex that focuses on continuing care and rehabilitation. It also engages some 2,000 volunteers and trains more than 550 nurses annually. The RRI has more than 380 research studies underway related to brain health and aging. An independent benchmarking study concluded that few institutions match the breadth and uniqueness of the integrated models of service delivery and the calibre of translational research at Baycrest.

Baycrest was recently selected by Neurological Health Charities of Canada as a national award recipient for innovation and leadership in brain health and aging. In September 2014, the federal government announced that 11 researchers from Baycrest Health Sciences and its world-renowned RRI will join the newly established Canadian Consortium on Neurodegeneration in Aging (CCNA), a national initiative to accelerate scientific understanding of dementia and other neurodegenerative diseases – an effort that will lead to more effective treatments and prevention strategies for Canadians.


Facts About Dementia

Nearly 750,000 Canadians are living with dementia. This number will increase to 1.4 million by 2031. Today, the combined direct (medical) and indirect (lost earnings) cost of dementia in Canada is $33 billion. This number will skyrocket to $293 billion a year by 2040. In 2011, caregivers spent 444 million unpaid hours a year looking after friends and loved ones diagnosed with dementia.

This represents $11 billion in lost income and 227,760 full-time jobs. By 2040, caregivers will be devoting 1.2 billion unpaid hours a year.

(Source: "A new way of looking at the impact of dementia in Canada" [2012]; Alzheimer Society of Canada.)


Baycrest Foundation President and CEO Garry Foster Quotes:

“Thanks to the long-standing support of Scotiabank, our players, volunteers, sponsors and the NHL Alumni Association, we’ve raised more than $27 million in the history of this event! This is a remarkable accomplishment and we have you to thank. Baycrest makes a difference in the lives of thousands of older adults every day, but we have a long way to go. Alzheimer’s and related dementias affect approximately 750,000 Canadian seniors and this number is expected to increase to 1.4 million by 2031. Baycrest’s research is helping us rethink brain health and aging.”

“Your participation in this unique hockey experience provides our researchers with the funds they need to understand Alzheimer’s and other age-related brain illnesses. The Baycrest NHL Alumni Brain Health Study and the world’s first Virtual Brain are just two examples of the groundbreaking work that is taking place right now at our world-renowned Rotman Research Institute. And we owe our thanks to you.”



Scroll To Top